PubRank

Diabetes, nutrition & metabolism (Diabetes Nutr Metab)

Journal PubWeight™ 155.14‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 Food habits in a southern Italian town (Nicotera) in 1960 and 1996: still a reference Italian Mediterranean diet? 2001 1.41
2 Calcium antagonists and cardiovascular risk in patients with hypertension and Type 2 diabetes mellitus: evidence from the PIUMA Study. Progetto Ipertensione Umbria Monitoraggio Ambulatoriale. 1999 1.39
3 The dual-wave bolus feature in continuous subcutaneous insulin infusion pumps controls prolonged post-prandial hyperglycaemia better than standard bolus in Type 1 diabetes. 2004 1.18
4 Effects of metformin on glucagon-like peptide-1 levels in obese patients with and without Type 2 diabetes. 2004 1.11
5 Effect of sleep deprivation on insulin sensitivity and cortisol concentration in healthy subjects. 2000 1.08
6 Effectiveness of an uninterrupted procedure to transfer adolescents with Type 1 diabetes from the Paediatric to the Adult Clinic held in the same hospital: eight-year experience with the Parma protocol. 2004 1.07
7 Thyroid autoimmunity in children and adolescents with Type 1 diabetes mellitus. 1999 1.06
8 Cigarette smoking is a risk factor for nephropathy and its progression in type 2 diabetes mellitus. 2001 1.06
9 Determination of endothelial function and early atherosclerotic changes in healthy obese women. 2003 1.05
10 Diabetes in the pre-school child. 1999 1.04
11 Practical aspects of measuring microalbuminuria in diabetic patients. 2001 1.01
12 Acceptability and safety of a new 3.0 ml re-usable insulin pen (HumaPen) in clinical use. 1999 1.01
13 Progression and distribution of plantar pressure in Type 2 diabetic patients. 2004 1.00
14 Validation of the Italian version of the WHO-Well-Being Questionnaire (WHO-WBQ) and the WHO-Diabetes Treatment Satisfaction Questionnaire (WHO-DTSQ). 2004 1.00
15 Alpha-lipoic acid treatment ameliorates metabolic parameters, blood pressure, vascular reactivity and morphology of vessels already damaged by streptozotocin-diabetes. 2000 0.99
16 Relationship between patient practice-oriented knowledge and metabolic control in intensively treated Type 1 diabetic patients: results of the validation of the Knowledge and Practices Diabetes Questionnaire. 2000 0.95
17 Liver glycogenosis as early manifestation in type 1 diabetes mellitus. 2003 0.94
18 A prospective randomised-controlled pilot study for evaluating the teaching utility of interactive educational diabetes simulators. 2003 0.94
19 Genetics of Type 1 diabetes mellitus. 1999 0.94
20 Investigation on the accuracy of the blood glucose monitoring device Prestige IQ. 2003 0.93
21 Metabolic variations with oral antidiabetic drugs in patients with Type 2 diabetes: comparison between glimepiride and metformin. 2004 0.92
22 Two-year prospective evaluation of the factors affecting honeymoon frequency and duration in children with insulin dependent diabetes mellitus: the key-role of age at diagnosis. 2002 0.91
23 The Taq IA and Ser311 Cys polymorphisms in the dopamine D2 receptor gene and obesity. 2003 0.91
24 Amino acid availability controls muscle protein metabolism. 1999 0.91
25 Hyperuricaemia in Type 2 diabetes mellitus. 1999 0.91
26 Prevalence of the metabolic syndrome in a Turkish adult population. 2004 0.91
27 Anthropometry and body composition in northern Asian Indian patients with type 2 diabetes: receiver operating characteristics (ROC) curve analysis of body mass index with percentage body fat as standard. 2003 0.90
28 Estimation of risk for plantar foot ulceration in diabetic patients with neuropathy. 1999 0.90
29 Drug-induced severe hypoglycaemia in Type 2 diabetic patients aged 80 years or older. 2004 0.89
30 Technology integration for the provision of population-based equitable patient care: The Tayside Regional Diabetes Network--a brief description. 2001 0.89
31 Intensive insulin treatment in diabetic children. 2001 0.89
32 Predicting Type 2 diabetes using an electronic nose-based artificial neural network analysis. 2002 0.88
33 Effects of weight loss on insulin secretion and in vivo insulin sensitivity in obese diabetic and non-diabetic subjects. 2004 0.88
34 Effects of recombinant human leptin treatment as an adjunct of moderate energy restriction on body weight, resting energy expenditure and energy intake in obese humans. 2003 0.88
35 What we know about counterregulation in Type 2 diabetes. 2002 0.88
36 Prevalence of obstructive sleep apnoea in a sample of obese women: effect of menopause. 2004 0.87
37 Silybin-beta-cyclodextrin in the treatment of patients with diabetes mellitus and alcoholic liver disease. Efficacy study of a new preparation of an anti-oxidant agent. 2002 0.87
38 The interrelationship between insulin secretion and action in type 2 diabetes mellitus with different degrees of obesity: evidence supporting central obesity. 2003 0.87
39 The pathophysiology of hypoglycaemia in diabetes. 2002 0.87
40 Psychiatric distress and health-related quality of life in obesity. 2003 0.87
41 Heart rate variability and autonomic diabetic neuropathy. 2000 0.87
42 Role of neuron-glia interaction in the regulation of brain glucose utilization. 2002 0.87
43 Insulin effect on leucine kinetics in type 2 diabetes mellitus. 2002 0.86
44 Lispro insulin treatment in comparison with regular human insulin in type 2 diabetic patients living in nursing homes. 2002 0.86
45 Influence of patients' representations and beliefs about diabetes and its treatment on their adherence to therapy. 2001 0.86
46 Autonomic mechanism and defects in the glucagon response to insulin-induced hypoglycaemia. 2002 0.86
47 Homocysteine plasma levels are independently associated with insulin resistance in normal weight, overweight and obese pre-menopausal women. 2001 0.85
48 Health-related quality of life in obesity: the role of eating behaviour. 2000 0.85
49 The QUOVADIS Study: features of obese Italian patients seeking treatment at specialist centers. 2003 0.85
50 Nocturnal hypoglycaemia in children: the effects on cognitive function. 2002 0.85
Next 50